Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- The team shrank two years in a row.
Revenue
€ 46,117
▼ 97% vs 2024
Profit
Caution€ -95,051
▲ 79% vs 2024
Debts
High€ 500,249
▼ 65% vs 2024
ORTHOSPINE from Mechelen, company number BE0403015402, closed financial year 2025 with a result of € -95,051 after tax. For that financial year ORTHOSPINE recorded revenue of € 46,117 and equity of € -232,826. Compared with financial year 2024, the result moved from € -446,474 to € -95,051. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
What happened at ORTHOSPINE?
What happened at ORTHOSPINE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Lana Gybels stepped down as director. NBB
- Diogo Santos de Lima stepped down as director. NBB
- Levico BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 95,051. Source: NBB ↗
- Fh Impact Management BV stepped down as director. NBB
- Lana Gybels became a director. NBB
- D&Q Finexperts BV stepped down as director. NBB
- Diogo Santos de Lima became a director. NBB
In short
From € 1 million loss in 2021 to € 95,051 loss in 2025.
Paid € 146,550 in corporate taxes since 2021.
Pays suppliers within 101 days on average.
A new publication or filing at ORTHOSPINE? We notify you, reason included.
Follow ORTHOSPINENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Duomed Holding Benelux (100%).
Directors
According to the 2025 annual accounts
Director · represented by Frédéric Hoffmann
Also active at: DUOMED BELGIUM, ARCHER RESEARCH, Duomed Holding Benelux +2 more
since 2024 · until 2025
Lana Gybels
Director
since 2025 · until 2031
Director · represented by Kristof Marivoet
Also active at: Duomed Holding Benelux, Palex Duomed Holding
since 2024 · until 2025
Director · represented by Geert Kuys
Also active at: DUOMED BELGIUM, Duomed Holding Benelux, Palex Duomed Holding +1 more
since 2023 · until 2029
Diogo Santos de Lima
Director
since 2025 · until 2031
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Vaartdijk 90
2800 Mechelen
Lennikse Baan 451
1070 Anderlecht
Active since 1 November 1962
Rue de l'Industrie 30c
1400 Nivelles
Active since 18 September 2014
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 18 companies are registered at this address.
AXI
€ 26.7 million revenue · 2025
DUOMED BELGIUM same network
€ 113.3 million revenue · 2025
AMISTA
€ 2.5 million gross margin · 2025
Duomed Holding Benelux same network
NESSI HOLDING
€ 391 gross margin · 2025
+13 more
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Domain
Domain
hospithera.com
Registered
1999-07-19
Registrar
Combell NV
Expires
2026-07-19
Website info
Features
Security
Details
- Company number
- 0403.015.402
- VAT number
- BE 0403.015.402
- Registered office
- Vaartdijk 90, 2800 Mechelen
- Names & denominations
- ORTHOSPINE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 January 1968
- Peppol
- Active · Active since 31 Mar 2026
- Contact
- hospithera.com info@tsc-be.com
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten